• -11%
  • New
1-Test Cyp 100 - Dihydroboldenone | Dragon Pharma
search
  • 1-Test Cyp 100 - Dihydroboldenone | Dragon Pharma

1-Test Cyp 100

$39.00
$34.71 Save 11%

Dihydroboldenone

1-Test Cyp 100 (DHB)β€’100 mg/ml
Class 5-AR Reduced Boldenone Analogue
Half-Life ~8 days (Cypionate ester)
Anabolic Ratio 200
Androgenic Ratio 100
Aromatisation None
Form Injection, 10ml

Quantity

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

1-Test Cyp 100 (DHB) β€” Dihydroboldenone Cypionate by Dragon Pharma

1-Test Cyp 100 is Dragon Pharma's formulation of Dihydroboldenone Cypionate (DHB) at 100mg/ml β€” the 5-alpha reduced form of Boldenone (Equipoise), carrying an anabolic ratio of 200 and androgenic ratio of 100 with zero aromatisation. DHB is structurally to Boldenone what DHT is to testosterone β€” the 5-alpha reduced metabolite that cannot aromatise, produces harder, drier muscle gains, and carries greater androgenic activity in androgen-sensitive tissues. It is also widely noted for significant injection site pain that requires specific management strategies.

Also searched as: DHB, Dihydroboldenone Cypionate, 1-Testosterone Cypionate, 1-Test Cyp, DHB Dragon Pharma.

What DHB Is β€” The Dihydroboldenone Structure

The relationship between DHB and Boldenone (EQ) mirrors that between DHT and testosterone:

  • Boldenone (Equipoise) is a mild aromatising AAS with anabolic ratio ~100 and androgenic ratio ~50. It aromatises to estradiol at approximately 50% the rate of testosterone
  • Dihydroboldenone (DHB) is the 5-alpha reduced form of Boldenone β€” exactly as DHT is the 5-alpha reduced form of testosterone. The 5-AR enzyme reduces the double bond at the C1-C2 position of Boldenone, producing DHB
  • Like DHT versus testosterone: DHB cannot aromatise (the 5-alpha reduction prevents aromatase from acting on it), has higher androgenic potency than its parent compound, and produces harder, more defined gains without water retention
  • DHB's anabolic ratio of 200 is double testosterone's (100) β€” making it genuinely anabolic β€” while the androgenic ratio of 100 matches testosterone exactly. This anabolic:androgenic profile (2:1 ratio) is superior to testosterone's 1:1 while producing no estrogen
  • DHB does not convert to DHT via 5-AR (it already is the 5-AR reduced form) β€” the standard Finasteride concern about DHT conversion does not apply

DHB vs Boldenone (EQ) β€” The Parent/Reduced Form Comparison

Parameter DHB (Dihydroboldenone) Boldenone (EQ)
Anabolic ratio 200 ~100
Androgenic ratio 100 ~50
Aromatisation None ~50% of testosterone rate
5-AR conversion Already 5-AR reduced β€” no further conversion Converts to DHB via 5-AR
Water retention None β€” dry gains Minimal from modest aromatisation
Erythropoiesis Less pronounced than EQ Pronounced β€” significant RBC increase
Injection pain Significant β€” specific management required Minimal
Available esters Cypionate (this product) Undecylenate (EQ 300/500)

The Injection Pain Reality β€” An Honest Assessment

DHB's injection site pain is consistently underrepresented in competitor content and must be addressed directly:

  • Dihydroboldenone Cypionate is notorious in the bodybuilding community for producing significant, sometimes severe injection site pain β€” not the mild post-injection soreness associated with compounds like Testosterone Enanthate, but pronounced pain, swelling and sometimes redness lasting 3-7 days after each injection
  • The mechanism is not fully established but is believed to involve the compound's interaction with local tissue at the injection site β€” DHB at higher concentrations in a small oil depot is particularly irritating to surrounding muscle tissue
  • Management strategies that meaningfully reduce (but do not eliminate) pain: diluting DHB with a less irritating oil compound (MCT oil alone, or drawing testosterone enanthate into the same syringe) β€” a 50:50 blend of DHB with another compound typically reduces pain substantially; limiting per-site injection volume to 1ml maximum; strict site rotation with minimum 48-72 hours before reinjecting the same site; using a slow, controlled injection technique with a smaller gauge needle
  • Users who cannot tolerate the injection site pain from DHB are not making poor choices by switching to alternative lean mass compounds β€” this is a real and significant practical limitation

Effects and Benefits

  • Lean, dry mass gains β€” no aromatisation means no water retention; gains are quality muscle tissue
  • Anabolic ratio of 200 β€” double testosterone's anabolic potency at equivalent mg doses
  • No AI required for DHB itself β€” zero estrogenic activity from this compound
  • No conversion to DHT via 5-AR β€” already the 5-AR reduced form; no additional androgenic scalp/prostate activity from 5-AR conversion
  • Moderately long duration from Cypionate ester β€” ~8-day half-life, twice-weekly injection
  • Hardness and muscle density improvement β€” consistent with non-aromatising lean compounds

Dosage and Administration

Experience Level Weekly Dose Volume at 100mg/ml Frequency Notes
First DHB cycle 200–300 mg/week 2–3 ml/week Twice weekly (1–1.5ml per site) Assess pain tolerance; blend with Test E if needed
Experienced 300–400 mg/week 3–4 ml/week Twice weekly Keep per-site volume ≀1ml to manage pain

Given injection pain, blending DHB in the same syringe with Testosterone Enanthate or Masteron Enanthate at 50:50 is a widely used strategy that significantly reduces site discomfort. The Cypionate ester provides ~8-day half-life β€” twice-weekly injection maintains stable blood levels. The testosterone base is strongly recommended alongside DHB; DHB alone provides no esterogenic support and complete HPG suppression still occurs.

Comments (0)
No customer reviews for the moment.